Standard BioTools Inc.LABNASDAQ

Revenue (LTM)

$85M

-51.1% YoY

Net Income (LTM)

$-75M

+46.1% YoY

Free Cash Flow

$-83M

Revenue CAGR (5Y)

-10.1%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	131	98↓25.0%	106↑8.6%	174↑64.0%	85↓51.1%
Gross Profit	69	37↓46.6%	50↑36.2%	84↑67.0%	43↓49.5%
Operating Income	-67	-116↓72.3%	-77↑34.1%	-175↓128.8%	-93↑46.8%
Net Income	-59	-190↓220.9%	-75↑60.7%	-139↓86.0%	-75↑46.1%
EBITDA	-44	-174↓292.1%	-54↑68.6%	-118↓116.9%	-95↑19.6%
EPS Diluted	-0.78	-2.43↓211.5%	-0.94↑61.3%	-0.52↑44.7%	-0.20↑61.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	28	81↑185.8%	52↓36.4%	167↑222.5%	118↓29.1%
Total Current Assets	72	209↑189.8%	158↓24.2%	376↑137.6%	454↑20.9%
Total Assets	275	390↑41.8%	323↓17.2%	612↑89.5%	568↓7.3%
Total Current Liabilities	50	43↓12.4%	109↑151.7%	66↓39.7%	108↑64.4%
Total Liabilities	181	472↑161.2%	471↓0.1%	141↓70.2%	143↑2.0%
Total Equity	95	-81↓186.1%	-148↓81.7%	472↑418.6%	424↓10.1%
Total Debt	112	103↓8.1%	98↓4.3%	33↓66.4%	31↓6.6%
Net Debt	83	21↓74.3%	47↑117.9%	-134↓387.6%	-87↑34.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-44	-89↓102.8%	-43↑51.6%	-143↓231.4%	-74↑48.2%
Capital Expenditure	-13	-4↑71.2%	-3↑26.0%	-8↓195.1%	-8↑0.6%
Free Cash Flow	-57	-93↓62.6%	-46↑50.5%	-152↓229.2%	-83↑45.6%
Stock-Based Comp	16	15↓7.6%	13↓11.8%	32↑141.8%	30↓6.7%
Net Change in Cash	-40	53↑231.9%	-30↓156.4%	116↑490.0%	-48↓141.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance